Charles River splits off and divests CDMO business

Charles River splits off and divests CDMO business

Charles River Laboratories International Inc. has sold off its CDMO business QS Pharma LLC, saying the small-molecule manufacturing business was “not optimized” within the firm's portfolio.

Teewinot ups cannabinoid production capabilities

Teewinot ups cannabinoid production capabilities

Image: iStock/toons17

Is the return of the one-stop-shop model just a CMO marketing ploy?

HPCTC adopts biometric fingerprint tech to register patients

HPCTC adopts biometric fingerprint tech to register patients

PRA and Takeda establish new joint venture in Japan

PRA and Takeda establish new joint venture in Japan

See More Headlines

Clinical Development

Image: iStock/raphspam

Strategic CRO takes $100m hit from Pfizer's shelved PCSK9 candidate

Graham Cotton, Senior R&D Group Leader, Almac Discovery; Tracy Robson; and Professor Tim Harrison, VP Discovery Chemistry, Almac Discovery.

Almac Discovery and RCSI enter research collaboration

iStock/wildpixel

Quotient buys QS Pharma in latest US expansion move

See More in Clinical Development

Commercial Services

ACRP developed CRA framework open for comment

ACRP develops framework in response to 'significant' CRA shortage

Serialization demand drives Antares expansion at new headquarters

Serialization demand drives Antares expansion at new headquarters

MedNet releases updated eClinical solution

MedNet releases updated eClinical solution

See More in Commercial Services

Contract Manufacturing

Image: iStock/cacaroot

Bio-outsourcing share to drop as Big Pharma invests heavily in-house, analyst

Evotec to hire across all sites with new €90m Novo investment

Evotec to hire across all sites with new €90m Novo investment

BriaCell submits regulatory CMC amendment for breast cancer vaccine

BriaCell files CMC amendment and preps for breast cancer vaccine trial

See More in Contract Manufacturing

Preclinical Research

Parkinson’s research slowed by study design flaws

Report: study design flaws slowing Parkinson's research

Mouse model program looks to speed drug discovery

Mouse model program looks to speed drug discovery

AMRI gains new tech through strategic alliance

AMRI gains new drug discovery tech through strategic alliance

See More in Preclinical Research

Popular News

LabCorp in talks to buy the CRO PPD for $8Bn

LabCorp in talks to buy PPD for $8Bn

Kitov CEO questioned over Ph III data concerns

Kitov CEO questioned over Ph III data concerns

Charles River splits off and divests CDMO business

Charles River splits off and divests CDMO business

Galleries

Videos

Audio

Latest Products

See more products